m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00229)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
DKC1
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3 | ||
Cell Line | Pancreatic islets | Mus musculus |
Treatment: Mettl3 knockout mice
Control: Mettl3 flox/flox mice
|
GSE155612 | |
Regulation |
|
logFC: 6.68E-01 p-value: 1.04E-03 |
More Results | Click to View More RNA-seq Results | |
Representative RIP-seq result supporting the interaction between DKC1 and the regulator | ||
Cell Line | MDA-MB-231 | Homo sapiens |
Regulation | logFC: 1.61E+00 | GSE60213 |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | CircMEG3 inhibits the expression of m6A methyltransferase METTL3 dependent on HULC. Moreover, CircMEG3 inhibits the expression of H/ACA ribonucleoprotein complex subunit DKC1 (DKC1), a component of telomere synthetase H/ACA ribonucleoprotein (RNP; catalyst RNA pseudouracil modification) through METTL3 dependent on HULC. These observations provide important basic information for finding effective liver cancer therapeutic targets. | |||
Target Regulation | Down regulation | |||
Responsed Disease | Liver cancer | ICD-11: 2C12 | ||
In-vitro Model | Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 |
In-vivo Model | Athymic BALB/c mice were injected with LCSC cells at the armpit area subcutaneously. The mice were then sacrificed and the tumors recovered. | |||
Liver cancer [ICD-11: 2C12]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | CircMEG3 inhibits the expression of m6A methyltransferase METTL3 dependent on HULC. Moreover, CircMEG3 inhibits the expression of H/ACA ribonucleoprotein complex subunit DKC1 (DKC1), a component of telomere synthetase H/ACA ribonucleoprotein (RNP; catalyst RNA pseudouracil modification) through METTL3 dependent on HULC. These observations provide important basic information for finding effective liver cancer therapeutic targets. | |||
Responsed Disease | Liver cancer [ICD-11: 2C12] | |||
Target Regulator | Methyltransferase-like 3 (METTL3) | WRITER | ||
Target Regulation | Down regulation | |||
In-vitro Model | Huh-7 | Adult hepatocellular carcinoma | Homo sapiens | CVCL_0336 |
In-vivo Model | Athymic BALB/c mice were injected with LCSC cells at the armpit area subcutaneously. The mice were then sacrificed and the tumors recovered. | |||